NCT06699407

Qishenyiqi for Ventricular Remodeling After Myocardial Infarction

Efficacy and Safety of Qishenyiqi Dripping Pills in Patients With Ventricular Remodeling and Chronic Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 210 (estimated)
• Sponsor: Qilu Hospital of Shandong University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The effects of Qishenyiqi dripping pill on cardiac remodeling in patients with chronic stable heart failure have not been reported. This project aims to clarify the efficacy and safety of Qishenyiqi in patients with chronic heart failure after myocardial infarction. Patients with chronic stable heart failure after myocardial infarction were selected and randomly divided into two groups: the treatment group was treated with Qishenyiqi dripping pills; The control group was given placebo treatment. After 12 months of follow-up, the effects of Qishenyiqi on cardiac remodeling and function and cardiovascular adverse events were evaluated. The results are helpful to provide a new treatment strategy for chronic heart failure.

Conditions

• Chronic Stable Heart Failure

Interventions

Type	Name	Description
DRUG	Qishenyiqi dripping pills	Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months
DRUG	Placebo	Placebo, 1 bag once, three times a day, 12 months

Timeline

• Start date: 2024-11-20
• Primary completion: 2026-12-31
• Completion: 2027-12-31
• First posted: 2024-11-21
• Last updated: 2024-11-21

Locations

3 sites across 1 country: China